April 17, 2013 ·
Leave a comment
Industry Insights from Paul Meade, M.Sc, MPH
Allison Murphy and I had the pleasure of participating in the MSL Society’s inaugural global conference and gala in Philadelphia earlier this month. At Thought Leader Select, we always enjoy the opportunity to meet some of our great colleagues in medical affairs in the pharmaceutical, biotechnology, and device industries, but this event proved to be really special.
Since joining our company last year, Allison has continued to make a real impact in the medical affairs community. After serving much of the last decade in Eli Lilly’s medical affairs division in support of the company’s endocrinology portfolio, Allison has brought a wealth of medical affairs expertise to Thought Leader Select. This expertise has continued to evolve, even as a consultant, through her membership and advisory board participation with the MSL Society, a dynamic group that we are proud to support as a company.
Dr. Samuel Dyer, the founder and head of the MSL Society, approached us a few months ago, asking for help with the burgeoning organization’s first global event. As a veteran of the industry myself, I have participated in many events through the years, as a participant, speaker, and sponsor. I must admit that I was more than a little skeptical about another conference/event series emerging in a space with ... read more »
TAGS: 
Allison Murphy Bayer biotechnology clinical trials CROs David Cram diagnostics Eli Lilly Global Prairie key opinion leaders in medicine KOL collaborations KOL engagement KOL strategy medical affairs medical devices medical science liaisons Mitch Trujillo MSL Society MSL Society Global Conference and Gala MSLs Paul Meade pharmaceuticals Quintiles Samuel Dyer Stewart Rosen Thought Leader Select thought leaders in medicine
February 7, 2013 ·
Leave a comment
For Immediate Release
February 7, 2013 (Chapel Hill, NC) The Medical Science Liaison Society (MSL Society) is planning its first global conference and gala for April 2013.
The event will take place at Philadelphia’s Hyatt at the Broadview on South Broad Street, from April 1-3. The 2013 MSL Society Conference and Gala is the first event of its kind, a tangible extension of the non-profit organization’s mission to bring together global medical affairs professionals for education and networking in an effort to support the profession.
Attendees will include Medical Affairs and MSL Leadership, as well as other professionals focusing on key topic including KOL access, HEOR, clinical trials, clinical investigation, key opinion leader relationship management, and medical communications. The emerging roster of speakers includes luminaries from the world of medical affairs, including Dr. Stewart Rosen, Vice President of Medical Affairs at Quintiles, Dr. Robert Ang, Vice President of Medical Affairs at Cadence Pharmaceuticals, and Dr. Elizabeth Kupferer, Director of Medical Affairs at Sequenom. 
Highlights of the three-day event include a welcome reception on day one, followed by a full day of education and networking, the gala dinner to culminate day two, and a final round of education and networking on day three.
“We’ve planned our first live conference with the needs ... read more »
TAGS: Allison Murphy biotechnology Cadence Pharmaceuticals clinical investigation clinical trials Elizabeth Kupferer HEOR key opinion leaders KOL management KOLs Kristen Smithwick medical affairs medical affairs education medical affairs networking medical devices medical science liaisons MSL leadership MSL Society MSL Society Global Conference and Gala patient health pharmaceuticals public health Quintiles Robert Ang Samuel Dyer Sequenom Stewart Rosen Thought Leader Select thought leaders in medicine
April 26, 2012 ·
Leave a comment
April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:
Gastroenterology
Hepatology
Infectious Disease
Internal Medicine
For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, ... read more »
TAGS: basic and clinical research biopharmaecutical consulting firm diagnostics drug development gastroenterology geographic impact of key opinion leaders health care professionals Hepatitis C hepatology HIV infectious diseases internal medicine key opinion leader relationships key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling KOL strategy Kristen Smithwick market access medical affairs medical device medical marketing medical meetings speakers patient health payer marketing physicians pipeline planning pricing and reimbursement professional network mapping public health scientific journal publishing Thought Leader Select thought leaders in medicine treatment guidelines
February 28, 2012 ·
Leave a comment
Industry Insights from Paul Meade, M. Sc., MPH
There has been quite a lot of noise lately regarding the use of social network techniques to find key opinion leaders in the medical profession. Whether it’s through what some call social network analysis or the creation of health care professional-only social networks, proponents of these methods like to think that they are reinventing thought leadership and its metrics.
In fact, some advocates even suggest they can find more key opinion leaders in the medical field than by using other tried and tested, and sometimes validated approaches. Can this be true? Well, it depends on how these companies, and better yet, how the end users of their services, define thought leaders or key opinion leaders (KOLs).
There are those with backgrounds in information technology, as well as social sciences such as sociology and psychology, and other areas outside healthcare who are trying to redefine thought leadership in medicine to fit the template of the products they are selling. For example, some of them have taken concepts of social interactions and applied them to finding those medical experts that either publish together or even present at similar conferences. But just because someone writes a paper with someone else doesn’t mean they are both KOLs. In fact, the contrary is often the case.
So let’s back up and ... read more »
TAGS: clinical practice diabetes health behaviors health care professional social networks information technology key opinion leaders KOL identification KOL profiling KOLs physician social networks psychology public health publication collaborations publishing scientific journals scientific research social networks sociology thought leaders thought leaders in medicine thought leadership
